Reviews
20 June 2018
Vol. 12 No. 2 (2018)
https://doi.org/10.4081/itjm.2018.961

Postprandial hyperglycemia: a new frontier in diabetes management?

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Diabetes, postprandial hyperglycemia, cardiovascular risk factors, insulin faster aspart, flash glucose monitoring.
5103
Views
1394
Downloads
2991
HTML

Authors

Ada Maffettone
adamaff@hotmail.com
Department of Cardiovascular Medicine and Dysmetabolic Diseases, AORN Ospedali dei Colli, Naples, Italy.
Massimo Rinaldi
Consultant of Internal Medicine, Villa delle Magnolie, Caserta, Italy.
Andrea Fontanella
Department of Internal Medicine, Ospedale del Buonconsiglio, Fatebenefratelli, Naples, Italy.
Postprandial hyperglycemia is one of the earliest abnormalities of glucose homeostasis associated with type-2 diabetes and it is markedly exaggerated in diabetic patients with fasting hyperglycemia. An extensive body of data demonstrates a strong association between postprandial glucose levels and cardiovascular risk factors. Our article will focus on the concept of postprandial hyperglycemia, its physiopathology, its role on cardiovascular risk factors and the effects of new devices and a new faster insulin analog on postprandial hyperglycemia.

Altmetrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Ada Maffettone, Department of Cardiovascular Medicine and Dysmetabolic Diseases, AORN Ospedali dei Colli, Naples
Dr, PhD

How to Cite



Postprandial hyperglycemia: a new frontier in diabetes management?. (2018). Italian Journal of Medicine, 12(2), 108-115. https://doi.org/10.4081/itjm.2018.961

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.